Molecular Mechanisms Responsible for Therapeutic Potential of Mesenchymal Stem Cell-Derived Secretome.
Harrell CR, Fellabaum C, Jovicic N, Djonov V, Arsenijevic N, Volarevic V. · 2019
Read Molecular Mechanisms Responsible for Therapeutic Potential of Mesenchymal Stem Cell-Derived Secretome. by Harrell CR, Fellabaum C, Jovicic N, Djonov V, Arsenijevic N, Volarevic V. (2019) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc6562906.txt.
Description
Harrell and co-authors review the mesenchymal stem cell secretome — the cocktail the cells release rather than the cells themselves — writing in Cells. The secretome bundles soluble proteins, nucleic acids, lipids and extracellular vesicles. Study after study finds it heals much like transplanted stem cells do, while skipping their risks, such as stray differentiation after engraftment.
That profile suits emergencies. Unlike cells, which need weeks of culture, secretome stocks can be made in bulk from commercial lines and used for crises like liver failure, stroke or heart attack. The review traces how its growth and immune-calming factors switch on anti-death, pro-survival pathways in injured tissue across the liver, lungs, joints, gut, heart and nervous system.
Catalog record
| CREATOR | Harrell CR, Fellabaum C, Jovicic N, Djonov V, Arsenijevic N, Volarevic V. |
|---|---|
| YEAR | 2019 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 116 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |